Vidar Wendel-Hansen
Chief Tech/Sci/R&D Officer at TOLERANZIA AB
Network origin in Vidar Wendel-Hansen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Resistentia Pharmaceutical's business strategy is to develop and commercialize immunotherapy as a second generation therapy to monoclonal antibodies for the treatment of chronic diseases. Resistentia’s most advanced program is an immunotherapy against allergy/asthma – a growing health problem with a large unmet medical need. In contrast to existing therapies, which are largely symptomatic, Resistentia’s novel immunotherapeutic approach targets the cause of the allergic reactions, rather than the symptoms. In addition, Resistentia is developing an immunotherapy for the treatment of rheumatoid arthritis. The project is currently in discovery phase.
16
| Extinct | Pharmaceuticals: Major | 16 |
Public Company | Biotechnology | 13 | |
Karolinska Institutet
11
| College/University | Other Consumer Services | 11 |
Public Company | Biotechnology | 6 | |
Public Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vidar Wendel-Hansen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Provell Pharmaceuticals LLC
Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member Director/Board Member | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chairman Corporate Officer/Principal | |
MEDIVIR AB | Pharmaceuticals: Major | Chairman President | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
RECIPHARM AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Founder | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
University of Stockholm | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
Henley Management College | College/University | Masters Business Admin Masters Business Admin | |
University of Gothenburg | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Chief Executive Officer | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SymCel AB
SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Handelshögskolan i Göteborg | College/University | Graduate Degree Graduate Degree | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
PHARMACOLOG I UPPSALA AB | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Healthcap 1999 GP AB
Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Laboratoire HRA-Pharma SA
Laboratoire HRA-Pharma SA Pharmaceuticals: MajorHealth Technology Laboratoire HRA Pharma SA manufactures and distributes pharmaceutical products. Its products include contraceptive pills such as the pill of two days later and EllaOne. The company was founded by Andre Ulmann in 1996 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder Chairman | |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Recip AB
Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
AstraZeneca R&D Mölndal | Corporate Officer/Principal Corporate Officer/Principal | ||
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Cormorant Pharmaceuticals AB
Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Trimb Healthcare AB
Trimb Healthcare AB Pharmaceuticals: MajorHealth Technology Trimb Healthcare AB operates as a over the counter pharmaceutical company. It focuses on sales, marketing and development of prescription free pharmaceuticals, and consumer healthcare products. The company was founded by Mikael Pålsson in 2012 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor Chairman | |
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Founder Founder Director/Board Member | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Trimb Holding AB
Trimb Holding AB Financial ConglomeratesFinance Part of Karo Healthcare AB, Trimb Holding AB operates as a holding Swedish company with interest in pharmaceuticals. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member Chairman | |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NANOLOGICA AB | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistics
International
Sweden | 36 |
United Kingdom | 8 |
United States | 4 |
France | 4 |
Denmark | 2 |
Sectoral
Health Technology | 30 |
Commercial Services | 7 |
Consumer Services | 7 |
Finance | 6 |
Distribution Services | 2 |
Operational
Director/Board Member | 298 |
Chairman | 102 |
Corporate Officer/Principal | 89 |
Independent Dir/Board Member | 38 |
Chief Executive Officer | 33 |
Most connected contacts
Insiders | |
---|---|
Sven Håkan Björklund | 46 |
Thomas Bengt Eldered | 41 |
Johan Rutger Christenson | 35 |
Carl-Johan Spak | 35 |
Deborah Harland | 27 |
Gisela Marie Sitbon | 26 |
Staffan Lindstrand | 25 |
Lars Gerhard Linzander | 24 |
Mathieu Simon | 22 |
Anders Harald Milton | 20 |
Jan Anders Vedin | 19 |
Jonas Karl Olaf Brambeck | 19 |
Jonas Frick | 18 |
Kent Alan Gossett | 16 |
Alf E. A. Lindberg | 16 |
- Stock Market
- Insiders
- Vidar Wendel-Hansen
- Company connections